Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

Related Citations for PubMed (Select 17429412)

1.

Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression.

Frye MA, Watzl J, Banakar S, O'Neill J, Mintz J, Davanzo P, Fischer J, Chirichigno JW, Ventura J, Elman S, Tsuang J, Walot I, Thomas MA.

Neuropsychopharmacology. 2007 Dec;32(12):2490-9. Epub 2007 Apr 11.

2.

Mania, glutamate/glutamine and risperidone in pediatric bipolar disorder: a proton magnetic resonance spectroscopy study of the anterior cingulate cortex.

Moore CM, Biederman J, Wozniak J, Mick E, Aleardi M, Wardrop M, Dougherty M, Harpold T, Hammerness P, Randall E, Lyoo IK, Renshaw PF.

J Affect Disord. 2007 Apr;99(1-3):19-25. Epub 2006 Sep 26.

3.

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study.

Auer DP, Pütz B, Kraft E, Lipinski B, Schill J, Holsboer F.

Biol Psychiatry. 2000 Feb 15;47(4):305-13.

PMID:
10686265
4.

Glutamatergic effects of divalproex in adolescents with mania: a proton magnetic resonance spectroscopy study.

Strawn JR, Patel NC, Chu WJ, Lee JH, Adler CM, Kim MJ, Bryan HS, Alfieri DC, Welge JA, Blom TJ, Nandagopal JJ, Strakowski SM, DelBello MP.

J Am Acad Child Adolesc Psychiatry. 2012 Jun;51(6):642-51. doi: 10.1016/j.jaac.2012.03.009. Epub 2012 May 5.

PMID:
22632623
5.

Neurochemical alterations in adolescent bipolar depression: a proton magnetic resonance spectroscopy pilot study of the prefrontal cortex.

Patel NC, Cecil KM, Strakowski SM, Adler CM, DelBello MP.

J Child Adolesc Psychopharmacol. 2008 Dec;18(6):623-7. doi: 10.1089/cap.2007.151.

6.

Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder.

Soeiro-de-Souza MG, Salvadore G, Moreno RA, Otaduy MC, Chaim KT, Gattaz WF, Zarate CA Jr, Machado-Vieira R.

Neuropsychopharmacology. 2013 Feb;38(3):468-75. doi: 10.1038/npp.2012.203. Epub 2012 Oct 17.

7.

Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.

Lan MJ, McLoughlin GA, Griffin JL, Tsang TM, Huang JT, Yuan P, Manji H, Holmes E, Bahn S.

Mol Psychiatry. 2009 Mar;14(3):269-79. doi: 10.1038/sj.mp.4002130. Epub 2008 Feb 5.

PMID:
18256615
8.

Elevated metabolites within dorsolateral prefrontal cortex in rapid cycling bipolar disorder.

Michael N, Erfurth A, Pfleiderer B.

Psychiatry Res. 2009 Apr 30;172(1):78-81. doi: 10.1016/j.pscychresns.2009.01.002. Epub 2009 Feb 23.

PMID:
19239983
9.

The glutamatergic system and its relation to the clinical effect of therapeutic-sleep deprivation in depression - an MR spectroscopy study.

Murck H, Schubert MI, Schmid D, Schüssler P, Steiger A, Auer DP.

J Psychiatr Res. 2009 Jan;43(3):175-80. doi: 10.1016/j.jpsychires.2008.04.009. Epub 2008 Jun 3.

PMID:
18533184
10.

Spectroscopic correlates of antidepressant response to sleep deprivation and light therapy: a 3.0 Tesla study of bipolar depression.

Benedetti F, Calabrese G, Bernasconi A, Cadioli M, Colombo C, Dallaspezia S, Falini A, Radaelli D, Scotti G, Smeraldi E.

Psychiatry Res. 2009 Sep 30;173(3):238-42. doi: 10.1016/j.pscychresns.2008.08.004. Epub 2009 Aug 13.

PMID:
19682864
11.
12.

Decreased glutamate/glutamine levels may mediate cytidine's efficacy in treating bipolar depression: a longitudinal proton magnetic resonance spectroscopy study.

Yoon SJ, Lyoo IK, Haws C, Kim TS, Cohen BM, Renshaw PF.

Neuropsychopharmacology. 2009 Jun;34(7):1810-8. doi: 10.1038/npp.2009.2. Epub 2009 Feb 4.

13.

Neurochemical effects of quetiapine in patients with bipolar mania: a proton magnetic resonance spectroscopy study.

Adler CM, DelBello MP, Weber WA, Jarvis KB, Welge J, Chu WJ, Rummelhoff E, Kim MJ, Lee JH, Strakowski SM.

J Clin Psychopharmacol. 2013 Aug;33(4):528-32. doi: 10.1097/JCP.0b013e3182905b77.

PMID:
23764689
14.

Region-specific glutamate changes in patients with unipolar depression.

Grimm S, Luborzewski A, Schubert F, Merkl A, Kronenberg G, Colla M, Heuser I, Bajbouj M.

J Psychiatr Res. 2012 Aug;46(8):1059-65. doi: 10.1016/j.jpsychires.2012.04.018. Epub 2012 May 15.

PMID:
22595871
15.

Proton magnetic resonance spectroscopy of bipolar disorder versus intermittent explosive disorder in children and adolescents.

Davanzo P, Yue K, Thomas MA, Belin T, Mintz J, Venkatraman TN, Santoro E, Barnett S, McCracken J.

Am J Psychiatry. 2003 Aug;160(8):1442-52.

PMID:
12900307
16.

Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.

Yildiz-Yesiloglu A, Ankerst DP.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):969-95. Epub 2006 May 4. Review. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):591.

PMID:
16677749
17.

A 1HMRS study of the anterior cingulate gyrus in euthymic bipolar patients.

Amaral JA, Tamada RS, Issler CK, Caetano SC, Cerri GG, de Castro CC, Lafer B.

Hum Psychopharmacol. 2006 Jun;21(4):215-20.

PMID:
16783812
18.

Glutamine and glutamate levels in children and adolescents with bipolar disorder: a 4.0-T proton magnetic resonance spectroscopy study of the anterior cingulate cortex.

Moore CM, Frazier JA, Glod CA, Breeze JL, Dieterich M, Finn CT, Frederick Bd, Renshaw PF.

J Am Acad Child Adolesc Psychiatry. 2007 Apr;46(4):524-34.

19.

Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole.

Brennan BP, Hudson JI, Jensen JE, McCarthy J, Roberts JL, Prescot AP, Cohen BM, Pope HG Jr, Renshaw PF, Ongür D.

Neuropsychopharmacology. 2010 Feb;35(3):834-46. doi: 10.1038/npp.2009.191. Epub 2009 Dec 2.

20.

Bipolar disorder comorbid with alcoholism: a 1H magnetic resonance spectroscopy study.

Nery FG, Stanley JA, Chen HH, Hatch JP, Nicoletti MA, Monkul ES, Lafer B, Soares JC.

J Psychiatr Res. 2010 Apr;44(5):278-85. doi: 10.1016/j.jpsychires.2009.09.006. Epub 2009 Oct 8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk